{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:55:09Z","timestamp":1789444509097,"version":"build-2803163510"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s10072-008-0986-2","type":"journal-article","created":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T17:24:03Z","timestamp":1224523443000},"page":"293-301","source":"Crossref","is-referenced-by-count":73,"title":["Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson\u2019s disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Hironori","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,31]]},"reference":[{"key":"986_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E. Hirsh","year":"1988","unstructured":"Hirsh E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334:345\u2013348","journal-title":"Nature"},{"key":"986_CR2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","volume":"337","author":"Y. Agid","year":"1991","unstructured":"Agid Y (1991) Parkinson\u2019s disease: pathophysiology. Lancet 337:1321\u20131324","journal-title":"Lancet"},{"key":"986_CR3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H. Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykeiwicz O et al (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"986_CR4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W. Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"986_CR5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","volume":"61","author":"K.F. Tipton","year":"1993","unstructured":"Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61:1191\u20131206","journal-title":"J Neurochem"},{"key":"986_CR6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-291X(90)90498-C","volume":"170","author":"E. Hasegawa","year":"1990","unstructured":"Hasegawa E, Takeshige K, Oishi T et al (1990) 1-Methylphenylpyridinium (MPP+) induces NADH-dependent superoxideformation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170:1049\u20131055","journal-title":"Biochem Biophys Res Commun"},{"key":"986_CR7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0006-8993(96)01271-1","volume":"749","author":"K. Sriram","year":"1997","unstructured":"Sriram K, Pai KS, Boyd MR, Ravindranath V (1997) Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res 749:44\u201352","journal-title":"Brain Res"},{"key":"986_CR8","doi-asserted-by":"crossref","unstructured":"Rice-Evans CA (1994) Formation of free radicals and mechanisms of action in normal biochemical processes and pathological states. In: Rice-Evans CA, Burdon RH (eds) Free radical damage and its control. Amsterdam Elsevier, pp 131\u2013153","DOI":"10.1016\/S0167-7306(08)60441-X"},{"key":"986_CR9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","volume":"991","author":"M.F. Beal","year":"2003","unstructured":"Beal MF (2003) Mitochondria, oxidative damage, and inflammation in Parkinson\u2019s disease. Ann NY Acad Sci 991:120\u2013131","journal-title":"Ann NY Acad Sci"},{"key":"986_CR10","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1016\/S0021-9258(17)36277-4","volume":"260","author":"A. Slivka","year":"1985","unstructured":"Slivka A, Cohen G (1985) Hydroxyl radical attack on dopamine. J Biol Chem 260:15466\u201315472","journal-title":"J Biol Chem"},{"key":"986_CR11","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1046\/j.1471-4159.1999.0732546.x","volume":"73","author":"M.J. LaVoice","year":"1999","unstructured":"LaVoice MJ, Hastings TG (1999) Peroxynitrite-and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J Neurochem 73:2546\u20132554","journal-title":"J Neurochem"},{"key":"986_CR12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","volume":"64","author":"T.G. Hastings","year":"1995","unstructured":"Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64:919\u2013924","journal-title":"J Neurochem"},{"key":"986_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"C.W. Olanow","year":"1999","unstructured":"Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson\u2019s disease. Annu Rev Nurosci 22:123\u2013144","journal-title":"Annu Rev Nurosci"},{"key":"986_CR14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0891-5849(02)01111-5","volume":"33","author":"R. Radi","year":"2002","unstructured":"Radi R, Cassina A, Hodara R et al (2002) Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33:1451\u20131464","journal-title":"Free Radic Biol Med"},{"key":"986_CR15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/1071576031000115651","volume":"37","author":"F.H. Khan","year":"2003","unstructured":"Khan FH, Sen T, Chakrabarti S (2003) Dopamine oxidation products inhibit Na+, K+-ATPase activity in crude synaptosomalmitochondrial fraction from rat brain. Free Radic Res 37:597\u2013601","journal-title":"Free Radic Res"},{"key":"986_CR16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.3080808","volume":"231","author":"R.J. D\u2019Amato","year":"1986","unstructured":"D\u2019Amato RJ, Lipman ZP, Snyder SH (1986) Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. Science 231:987\u2013989","journal-title":"Science"},{"key":"986_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002512-199914020-00004","volume":"14","author":"K.A. Jellinger","year":"1999","unstructured":"Jellinger KA (1999) The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson\u2019s disease. Drugs Aging 14:115\u2013140","journal-title":"Drugs Aging"},{"key":"986_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.pa.30.040190.002535","volume":"30","author":"L.J. Ignarro","year":"1990","unstructured":"Ignarro LJ (1990) Biosynthesis and metabolism of endotheliumderived nitric oxide. Ann Rev Pharmacol Toxicol 30:535\u2013560","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"986_CR19","first-page":"6268","volume":"88","author":"V.L. Dawson","year":"1991","unstructured":"Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH (1991) Nitric oxide mediates glutamate neurotoxicity in primary cultures. Proc Natl Acad Sci USA 88:6268\u20136371","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1073\/pnas.87.2.682","volume":"87","author":"D.S. Bredt","year":"1990","unstructured":"Bredt DS, Snyder SH (1990) Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:682\u2013685","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0166-2236(93)90109-Y","volume":"16","author":"S. Murphy","year":"1993","unstructured":"Murphy S, Simmons ML, Agullo L et al (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 16:323\u2013328","journal-title":"Trends Neurosci"},{"key":"986_CR22","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1523\/JNEUROSCI.14-09-05147.1994","volume":"14","author":"T.M. Dawson","year":"1994","unstructured":"Dawson TM, Snyder SH (1994) Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 14:5147\u20135159","journal-title":"J Neurosci"},{"key":"986_CR23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0092-8674(94)90268-2","volume":"78","author":"M.A. Marletta","year":"1994","unstructured":"Marletta MA (1994) Aspects concerning structure and catalysis. Cell 78:927\u2013930","journal-title":"Cell"},{"key":"986_CR24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","volume":"78","author":"C. Nathan","year":"1994","unstructured":"Nathan C, Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78:915\u2013918","journal-title":"Cell"},{"key":"986_CR25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1046\/j.1471-4159.1997.69041771.x","volume":"69","author":"D.A. Monte Di","year":"1997","unstructured":"Di Monte DA, Royland JE, Anderson A et al (1997) Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity. J Neurochem 69:1771\u20131773","journal-title":"J Neurochem"},{"key":"986_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","volume":"43","author":"S. Moncada","year":"1991","unstructured":"Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109\u2013142","journal-title":"Pharmacol Rev"},{"key":"986_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/A:1020605429535","volume":"14","author":"T. Araki","year":"1999","unstructured":"Araki T, Tanji H, Fujihara K et al (1999) Increases in [3H]FK-506 and [3H]L-NG-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation. Metab Brain Dis 14:21\u201331","journal-title":"Metab Brain Dis"},{"key":"986_CR28","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00702-003-0021-y","volume":"110","author":"Y. Muramatsu","year":"2003","unstructured":"Muramatsu Y, Kurosaki R, Watanabe H et al (2003) Cerebral alterations in a MPTP-mouse model of Parkinson\u2019s disease-an immunocytochemical study. J Neural Transm 110:1129\u20131144","journal-title":"J Neural Transm"},{"key":"986_CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","volume":"63","author":"D.S. Bredt","year":"1994","unstructured":"Bredt DS, Snyder SH (1994) A physiologic messenger molecule. Ann Rev Biochem 63:175\u2013195","journal-title":"Ann Rev Biochem"},{"key":"986_CR30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1471-4159.1995.64020936.x","volume":"64","author":"J.B. Schulz","year":"1995","unstructured":"Schulz JB, Matthews RT, Muqit MM et al (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 64:936\u2013939","journal-title":"J Neurochem"},{"key":"986_CR31","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1046\/j.1471-4159.1994.63062108.x","volume":"63","author":"G. Lonart","year":"1992","unstructured":"Lonart G, Johnson KM (1992) Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes. J Neurochem 63:2108\u20132117","journal-title":"J Neurochem"},{"key":"986_CR32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","volume":"87","author":"J.S. Beckman","year":"1990","unstructured":"Beckman JS, Beckman TW, Chen J et al (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620\u20131624","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0003-9861(92)90432-V","volume":"298","author":"J.S. Beckman","year":"1992","unstructured":"Beckman JS, Ischiropoulos H, Zhu L et al (1992) Kinetics of superoxide dismutase-and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys 298:438\u2013445","journal-title":"Arch Biochem Biophys"},{"key":"986_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0003-9861(92)90431-U","volume":"298","author":"H. Ischiropoulos","year":"1992","unstructured":"Ischiropoulos H, Zhu L, Chen J et al (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 298:431\u2013437","journal-title":"Arch Biochem Biophys"},{"key":"986_CR35","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"P.L. McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia and positive for HLS-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291","journal-title":"Neurology"},{"key":"986_CR36","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"100","author":"P. Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Choi DK et al (2003) Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease. Proc Natl Acad Sci USA 100:5473\u20135478","journal-title":"Proc Natl Acad Sci USA"},{"issue":"[Suppl1]","key":"986_CR37","first-page":"3","volume":"50","author":"B. Samuelsson","year":"1991","unstructured":"Samuelsson B (1991) Arachidonic acid metabolism: role in inflammation. Z Rheumatol 50[Suppl 1]:3\u20136","journal-title":"Z Rheumatol"},{"key":"986_CR38","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1002\/j.1875-9114.1997.tb03696.x","volume":"17","author":"S.E. Wenzel","year":"1997","unstructured":"Wenzel SE (1997) Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 17:3S\u201312S","journal-title":"Pharmacotherapy"},{"key":"986_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"W.L. Smith","year":"2000","unstructured":"Smith WL, DeWitt DL, Garavitro RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Ann Rev Biochem 69:145\u2013182","journal-title":"Ann Rev Biochem"},{"key":"986_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4547(19981001)54:1<1::AID-JNR1>3.0.CO;2-M","volume":"54","author":"G.M. Pasinetti","year":"1998","unstructured":"Pasinetti GM (1998) Cyclooxygenase and inflammation in Alzheimer\u2019s disease: experimental approaches and clinical interventions. J Neurosci Res 54:1\u20136","journal-title":"J Neurosci Res"},{"key":"986_CR41","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1432-1033.1997.00726.x","volume":"243","author":"M.K. Bauer","year":"1997","unstructured":"Bauer MK, Lieb K, Schulze-Osthoff K et al (1997) Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 243:726\u2013731","journal-title":"Eur J Biochem"},{"key":"986_CR42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00005072-199911000-00008","volume":"58","author":"L. Minghetti","year":"1999","unstructured":"Minghetti L, Walsh DT, Levi G, Perry VH (1999) In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines. J Neuropathol Exp Neurol 58:1184\u20131191","journal-title":"J Neuropathol Exp Neurol"},{"key":"986_CR43","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/13543784.8.10.1521","volume":"8","author":"M.K. O\u2019Banion","year":"1999","unstructured":"O\u2019Banion MK (1999) COX-2 and Alzheimer\u2019s disease: potential roles in inflammation and neurodegeneration. Expert Opin Invest Drugs 8:1521\u20131536","journal-title":"Expert Opin Invest Drugs"},{"key":"986_CR44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","volume":"991","author":"B.C. Hirsch","year":"2003","unstructured":"Hirsch BC, Breidert T, Rousselet E et al (2003) The role of glial reaction and inflammation in Parkinson\u2019s disease. Ann NY Acad Sci 991:214\u2013228","journal-title":"Ann NY Acad Sci"},{"key":"986_CR45","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"G.T. Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S et al (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403\u20131409","journal-title":"Nat Med"},{"key":"986_CR46","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0304-3940(02)00704-8","volume":"329","author":"Z.H. Feng","year":"2002","unstructured":"Feng ZH, Wang TG, Li DD et al (2002) Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett 329:354\u2013358","journal-title":"Neurosci Lett"},{"key":"986_CR47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","volume":"82","author":"T. Breidert","year":"2002","unstructured":"Breidert T, Callebert J, Heneka MT et al (2002) Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson\u2019s disease. J Neurochem 82:615\u2013624","journal-title":"J Neurochem"},{"key":"986_CR48","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"D.C. Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M et al (2002) Blockade of micro-glial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763\u20131771","journal-title":"J Neurosci"},{"key":"986_CR49","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/01.WNL.0000058760.13152.1A","volume":"60","author":"B.M. Ravina","year":"2003","unstructured":"Ravina BM, Fagan SC, Hart RG et al (2003) Neuroprotective agents for clinical trials in Parkinson\u2019s disease: a systematic assessment. Neurology 60:1234\u20131240","journal-title":"Neurology"},{"key":"986_CR50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0014-4886(03)00273-5","volume":"184","author":"S.D. Hurley","year":"2003","unstructured":"Hurley SD, O\u2019Banion MK, Song DD et al (2003) Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP-administration in monkeys. Exp Neurol 184:659\u2013668","journal-title":"Exp Neurol"},{"key":"986_CR51","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.exger.2007.04.010","volume":"42","author":"A. Vroon","year":"2007","unstructured":"Vroon A, Drukarch B, Bol JG et al (2007) Regional and cell-specific expression of GDNF in rat brain. Exp Gerontol 42:762\u2013771","journal-title":"Exp Gerontol"},{"key":"986_CR52","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0022-3565(25)38652-0","volume":"268","author":"T. Watanabe","year":"1994","unstructured":"Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268:1597\u20131604","journal-title":"J Pharmacol Exp Ther"},{"key":"986_CR53","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","volume":"93","author":"A.R. Amin","year":"1996","unstructured":"Amin AR, Attur MG, Thakker GD et al (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 93:14014\u201314019","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR54","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","volume":"95","author":"M. Endres","year":"1998","unstructured":"Endres M, Laufs U, Huang Z et al (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880\u20138885","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2006.12.011","volume":"1135","author":"A. Kreisler","year":"2007","unstructured":"Kreisler A, Gele P, Wiart JF et al (2007) Lipid-lowering drugs in the MPTP mouse model of Parkinson\u2019s disease: Fenofibrate has a neuroprotective effect, whereas benzafibrate and HMG-CoA reductase inhibitors do not. Brain Res 1135:77\u201384","journal-title":"Brain Res"},{"key":"986_CR56","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","volume":"71","author":"N. Aubin","year":"1998","unstructured":"Aubin N, Curet O, Deffois A, Carter C (1998) Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J Neurochem 71:1635\u20131642","journal-title":"J Neurochem"},{"key":"986_CR57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-999-0010-3","volume":"7","author":"R.A. Jones","year":"1999","unstructured":"Jones RA (1999) Etodolac: An overview of a selective COX-2 inhibitor. Inflammopharmacology 7:269\u2013275","journal-title":"Inflammopharmacology"},{"key":"986_CR58","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00702-008-0019-6","volume":"115","author":"H. Yokoyama","year":"2008","unstructured":"Yokoyama H, Takagi S, Watanabe Y et al (2008) Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. J Neural Transm 115:831\u2013842","journal-title":"J Neural Transm"},{"key":"986_CR59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm0996-1017","volume":"2","author":"P. Hantraye","year":"1996","unstructured":"Hantraye P, Brouillet E, Ferrante R et al (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2:1017\u20131021","journal-title":"Nat Med"},{"key":"986_CR60","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","volume":"93","author":"S. Przedborski","year":"1996","unstructured":"Przedborski S, Jackson-Lewis V, Yokoyama R et al (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93:4565\u20134571","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR61","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00005072-199804000-00006","volume":"57","author":"P.F. Good","year":"1998","unstructured":"Good PF, Hsu A, Werner P et al (1998) Protein nitration in Parkinson\u2019s disease. J Neuropathol Exp Neurol 57:338\u2013342","journal-title":"J Neuropathol Exp Neurol"},{"key":"986_CR62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0169-328X(98)00259-9","volume":"63","author":"D.J. Eve","year":"1998","unstructured":"Eve DJ, Nisbet AP, Kingsbury AE et al (1998) Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson\u2019s disease. Mol Brain Res 63:62\u201371","journal-title":"Mol Brain Res"},{"key":"986_CR63","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/niox.2000.0288","volume":"4","author":"E.M. Gatto","year":"2000","unstructured":"Gatto EM, Riobo NA, Carreras MC et al (2000) Overexpression of neutrophil neuronal nitric oxide synthase in Parkinson\u2019s disease. Nitric Oxide 4:534\u2013539","journal-title":"Nitric Oxide"},{"key":"986_CR64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neulet.2006.11.044","volume":"413","author":"C. Huerta","year":"2007","unstructured":"Huerta C, Sanchez-Ferrero E, Coto E et al (2007) No association between Parkinson\u2019s disease and three polymorphisms in the eNOS, nNOS, and iNOS genes. Neurosci Lett 413:202\u2013205","journal-title":"Neurosci Lett"},{"key":"986_CR65","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","volume":"74","author":"T. Dehmer","year":"2000","unstructured":"Dehmer T, Lindenau J, Haid S et al (2000) Deficiency of inducible nitric oxide synthase protects against MPTP neurotoxicity in vivo. J Neurochem 74:2213\u20132216","journal-title":"J Neurochem"},{"key":"986_CR66","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","volume":"44","author":"E.C. Hirsch","year":"1998","unstructured":"Hirsch EC, Hunot S, Damier P, Faucheux B (1998) Glial cells and inflammation in Parkinson\u2019s disease: a role in neurodegeneration? Ann Neurol 44:S115\u2013S120","journal-title":"Ann Neurol"},{"key":"986_CR67","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1046\/j.1471-4159.1999.0732469.x","volume":"73","author":"K.S. McNaught","year":"1999","unstructured":"McNaught KS, Jenner P (1999) Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinum-and 6-hydroxydopammine-induced toxicity in astrocytic\/ventral mesencephalic co-cultures. J Neurochem 73:2469\u20132476","journal-title":"J Neurochem"},{"key":"986_CR68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","volume":"72","author":"S. Hunot","year":"1996","unstructured":"Hunot S, Boissiere F, Faucheux B et al (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease. Neuroscience 72:355\u2013363","journal-title":"Neuroscience"},{"key":"986_CR69","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S. Hunot","year":"1997","unstructured":"Hunot S, Brugg B, Ricard D et al (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson\u2019s disease. Proc Natl Acad Sci USA 94:7531\u20137536","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR70","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.166.12.7527","volume":"166","author":"T.M. Tikka","year":"2001","unstructured":"Tikka TM, Koistinaho JE (2001) Minocycline provides neuroprotection against N-methyl-D-asparate neurotoxicity by inhibiting microglia. J Immunol 166:7527\u20137533","journal-title":"J Immunol"},{"key":"986_CR71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","volume":"51","author":"N. Popovic","year":"2002","unstructured":"Popovic N, Schubart A, Goetz BD et al (2002) Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51:215\u2013223","journal-title":"Ann Neurol"},{"key":"986_CR72","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","volume":"74","author":"L. Yang","year":"2003","unstructured":"Yang L, Sugama S, Chirichigno JW et al (2003) Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 74:278\u2013285","journal-title":"J Neurosci Res"},{"key":"986_CR73","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","volume":"19","author":"E. Diguet","year":"2004","unstructured":"Diguet E, Fernagut PO, Wei X et al (2004) Deleterious effects of minocycline in animal models of Parkinson\u2019s disease and Huntington\u2019s disease. Eur J Neurosci 19:3266\u20133276","journal-title":"Eur J Neurosci"},{"key":"986_CR74","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","volume":"96","author":"K. Sriram","year":"2006","unstructured":"Sriram K, Miller DB, O\u2019Callaghan P (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 96:706\u2013718","journal-title":"J Neurochem"},{"key":"986_CR75","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2004.09.028","volume":"324","author":"M. Chalimoniuk","year":"2004","unstructured":"Chalimoniuk M, Langfort J, Lukacova N, Marsala J (2004) Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice. Biochem Biophys Res Commun 324:118\u2013126","journal-title":"Biochem Biophys Res Commun"},{"key":"986_CR76","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.neuroscience.2006.04.022","volume":"141","author":"M. Chalimoniuk","year":"2006","unstructured":"Chalimoniuk M, Lukacova N, Marsala J, Langfort J (2006) Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuroscience 141:1033\u20131046","journal-title":"Neuroscience"},{"key":"986_CR77","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuint.2007.02.002","volume":"50","author":"M. Chalimoniuk","year":"2007","unstructured":"Chalimoniuk M, Langfort J (2007) The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem Int 50:821\u2013833","journal-title":"Neurochem Int"},{"key":"986_CR78","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1021\/tx970001d","volume":"10","author":"K. Castagnoli","year":"1997","unstructured":"Castagnoli K, Palmer S, Anderson A et al (1997) The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chem Res Toxicol 10:364\u2013368","journal-title":"Chem Res Toxicol"},{"key":"986_CR79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/exnr.1993.1207","volume":"124","author":"D.G. Schaar","year":"1993","unstructured":"Schaar DG, Sieber BA, Dreyfus CF, Black IB (1993) Regional and cell-specific expression of GDNF in rat brain. Exp Neurol 124:368\u2013371","journal-title":"Exp Neurol"},{"key":"986_CR80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(01)02866-9","volume":"916","author":"K. Nakajima","year":"2001","unstructured":"Nakajima K, Hida H, Shimano Y et al (2001) GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons. Brain Res 916:76\u201384","journal-title":"Brain Res"},{"key":"986_CR81","first-page":"277","volume":"60","author":"T. Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines and neurotrophins in Parkinson\u2019s disease. J Neural Transm Suppl 60:277\u2013290","journal-title":"J Neural Transm Suppl"},{"key":"986_CR82","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1046\/j.1471-4159.1998.70051859.x","volume":"70","author":"S.D. Skaper","year":"1998","unstructured":"Skaper SD, Floreani M, Negro A et al (1998) Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J Neurochem 70:1859\u20131868","journal-title":"J Neurochem"},{"key":"986_CR83","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0361-9230(01)00580-9","volume":"56","author":"A.A. Petersen","year":"2001","unstructured":"Petersen AA, Larsen KE, Behr GG et al (2001) Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death. Brain Res Bull 56:331\u2013335","journal-title":"Brain Res Bull"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0986-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-008-0986-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0986-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T04:19:38Z","timestamp":1738469978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-008-0986-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s10072-008-0986-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}